SHERESA WILSON: Open Payments
NPI 1114001237 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 21 payments from 12 companies in 2025. Trend: 2023 $304 · 2024 $403 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| PFIZER INC. | 1 | $31 |
| Alkermes, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
Products named: CAPLYTA, MAVYRET, FANAPT, Ozempic, ELIQUIS, VIVITROL, FREESTYLE LIBRE 3, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
